Modern Tools for Drug Discovery NIMBUS Biotechnology Modern Tools for Drug Discovery www.nimbus-biotechnology.com.

Slides:



Advertisements
Similar presentations
PhysChem Forum, 29 Nov 2006, Newhouse 1 Memories and the future: From experimental to in silico physical chemistry Han van de Waterbeemd AstraZeneca, DMPK.
Advertisements

Improving Candidate Quality Through the Prediction of Clinical Outcome.
Pharmacokinetics (PK) ®The study of the disposition of a drug ®The disposition of a drug includes the processes of ADME -  Absorption  Distribution.
Jörg KeldenichNov PhysChem Forum 1 Physicochemical Properties at Bayer HealthCare (Wuppertal) and Their Use in Medicinal Chemistry.
Lipinski’s rule of five
Module 2 # 2 Pharmacokinetics absorption of drugs drugs can be given iv, im, sc, orally (po) if given parenterally, they should.
Principles of Pharmacology. SOURCES AND NAMES OF DRUGS Sources of Drugs Many drugs are isolated from plants or chemically derived from plant substances.
ABSORPTION OF DRUGS DR.SOBAN SADIQ.
PHARMACOLOGY CH. 5 Pharmacokinetics. Pharmacokinetics explained… How the body handles the drugs that are administered to it, how the drugs are changed.
Asmah Nasser, M.D. Pharmacokinetics.
Pharmacokinetics Chapter 4.
Drug-Like Properties: Optimizing Pharmacokinetics and Safety During Drug Discovery Li Di and Edward H. Kerns ACS Short Course.
Pharmacokinetics Based on the hypothesis that the action of a drug requires presence of a certain concentration in the fluid bathing the target tissue.
Pharmacokinetics (PK): What the body does to the drug? Most drugs: Enter the body by crossing barriers Distributed by the blood to the site of action Biotransform.
ERT 420 BIOPHARMACEUTICAL ENGINEERING ERT 420 BIOPHARMACEUTICAL ENGINEERING Semester 1 Academic Session 2012/2013 HUZAIRY HASSAN School Of Bioprocess Engineering.
Pharmacology Department
ADME And PHARMACOKINETICS.
Is the passage of drug from its site of administration to its site of action through cell membranes. Sites of Administration Sites of action Cell membrane.
© 2004 by Thomson Delmar Learning, a part of the Thomson Corporation. Fundamentals of Pharmacology for Veterinary Technicians Chapter 4 Pharmacokinetics.
Prof. Hanan Hagar Pharmacology Department.  Is the fraction of unchanged drug that enters systemic circulation after administration and becomes available.
Toxicokinetics Toxicokinetics is the study of the drug movement around the body (Absorption, Distribution, metabolism, and Elimination) Toxicokinetic data.
1 Axcan Public Presentation for the FDA Pharmaceutical Science and Clinical Pharmacology Advisory Committee Meeting July 23, 2008.
PHARMACOKINETICS CH. 4 Part 2. GETTING IN ABSORPTION Definition – the movement of a drug from the site of administration into the fluids of the body.
1 Pharmacology Pharmacokinetics –Absorption –Distribution –Biotransformation (metabolism) –Excretion Pharmacodynamics –Receptor binding –Signal transduction.
Chapter 4 Pharmacokinetics Copyright © 2011 Delmar, Cengage Learning.
Basic Pharmacokinetics The time course of drug action Collected and Prepared By S.Bohlooli, PhD.
1 The Biopharmaceutical Classification System (BCS) Dr Mohammad Issa.
PHARMACOKINETICS Part 3.
Dr. Muslim Suardi, MSi., Apt. Faculty of Pharmacy University of Andalas.
!!!……Molecular Target Concept A gonist Antagonist.
Lipophilicity & Permeability 김연수. Chapter 5. Lipophilicity.
Pharmacology Department
Plasma Protein Binding
BASIC BIOPHARMACEUTICS
PHARMACOKINETICS Definition: quantitative study of drug absorption, distribution, metabolism, and excretion (ADME), and their mathematical relationship.
The Biopharmaceutical Classification System (BCS)
1 Pharmacokinetics: Introduction Dr Mohammad Issa.
Pharmacology Department
Chapter 6. pKa & Chapter 7. Solubility
© Paradigm Publishing, Inc.1 Chapter 2 Basic Concepts of Pharmacology.
김소연 Permeability OverviewPermeability FundamentalsPermeability EffectPermeability Structure Modification StrategiesProblem.
Background. For designing, discovering or developing a therapeutically relevant molecule, potency and selectivity to the target.
Blood-Brain Barrier 강 경 태 Contents 1. BBB Fundamentals 2. Effects of Brain Penetration 3. Structure-BBB Penetration Relationships 4. Structure.
Principles of Drug Action
Do We Need to Optimize Protein Binding in Drug Discovery? NEDMDG Summary Meeting Xingrong Liu, Ph.D. Genentech.
1 CHAPTER 2 DEFINITIONS RELATED TO PHARMACOKINETICS.
Basic Concepts of Pharmacology © Paradigm Publishing, Inc.
By : Dr. Roshini Murugupillai
Pharmacokienetic Principles (2): Distribution of Drugs
Lipinski’s rule of five
Physiology for Engineers
Basic Principles: PK By: Alaina Darby.
Chapter 3 PHARMACOKINETICS “What the body does to the drug” Lei Wang
The Biopharmaceutical Classification System (BCS)
Pharmacology I BMS 242 Lecture II (Continued)
CHAPTER 7 ABSORPTION KINETICS.
BTP 3822 BIOPHARMACEUTICS Quiz I
Pharmaceutics 2.
Pharmacology I BMS 242 Lecture II (Continued)
Scientific rationale for EU regulatory expectations concerning product composition in case of Class-I and Class-III medicinal products Dr Ridha BELAIBA.
Virtual Screening.
Identification & Assessment of NPS: an European Network
The Biopharmaceutical Classification System (BCS)
Pharmacokinetics: Drug Absorption
Basic Biopharmaceutics
Introduction to Pharmacology
Section 1, Lecture 2 PHARMACOKINETICS [DRUG]
Pharmacokinetics: Drug Absorption
Pharmacokinetics/Pharmacodynamics
Pharmacokinetics Asst Prof Dr Inam S. Arif
Presentation transcript:

Modern Tools for Drug Discovery NIMBUS Biotechnology Modern Tools for Drug Discovery

Modern Tools for Drug Discovery Innovative tools in “ready to go plates” Modern Tools for Drug Discovery NIMBUS Biotechnology

Modern Tools for Drug Discovery Bioavailability - an important issue Absorption Distribution Metabolism Excretion Pharmacokinetic Bioavailability

Modern Tools for Drug Discovery Absorption on a cellular level getting into the blood system Cross section of the gut wall TRANSPORT: passive paracellular passive transcellular active transcellular efflux blood stream

Modern Tools for Drug Discovery Distribution bloodstream Plasma/Tissue partitioning tissue e.g. brain Balance of interactions: lipophilicity vs. serum binding

Modern Tools for Drug Discovery Absorption on a cellular level getting into the blood system Cross section of the gut wall TRANSPORT: passive paracellular passive transcellular active transcellular efflux blood stream

Modern Tools for Drug Discovery K water/lipid K lipid/water Passive Transport in search of a good descriptor lipid bilayersmimicking cellular systems Passive Transport In search of a good descriptor

Modern Tools for Drug Discovery Passive Transport in search of a good descriptor “only absorption”additional information “hidden” K lipid/water Passive Transport In search of a good descriptor

Modern Tools for Drug Discovery Lipids and Proteins on Solid Supports Innovative tools in “ready to go plates” Prediction of absorption processes Unspecific binding to HSA Prediction of distribution

Modern Tools for Drug Discovery Determination of LIPOPHILICITY = Membrane Affinity (logMA) Non-covalently attached SINGLE LIPID BILAYER Different LIPID COMPOSITIONS Mimicking natural membranes High LONG TERM STABILITY 9 months DMSO ASSAY CONCENTRATION up to 5 % FAST SEPARATION due to the solid support TRANSIL ®

Modern Tools for Drug Discovery Validation log MA (charged and uncharged compounds) Comparison to liposome partitioning Good correlation with liposome approach

Modern Tools for Drug Discovery Validation fraction absorbed logMA correlates with fraction absorbed

Modern Tools for Drug Discovery High reproducibility from lot to lot Validation III Lot to Lot and Reproducibility High reproducibility from measurement to measurement

Modern Tools for Drug Discovery Validation IV logMA_NIMBUS 1:1 correlation logMA NIMBUS in-house data logMA Bayer Health Care Good lab to lab reproducibility Lab to Lab * Introduced by Seiffert at NIMBUS Meeting 2005

Modern Tools for Drug Discovery TRANSIL  -HSA Properties of the material random orientation immobilized on a soft and inert surface binding sites freely accessible stable in presence of organic modifiers (e.g. 5% DMSO)

Modern Tools for Drug Discovery good correlation with classical equilibrium dialysis TRANSIL  -HSA Validation TRANSIL ® -HSA vs. equilibrium dialysis

Modern Tools for Drug Discovery TRANSIL  - HSA Lot-to-lot reproducibility good lot-to-lot reproducibility

Modern Tools for Drug Discovery TRANSIL  -Assays Principles

Modern Tools for Drug Discovery TRANSIL ® Assays Available Formats TypeCompounds per 96-well plate Compounds per 384-well plate High-Throughput 2393 High-Precision 1045 High-Throughput High-Precision

Modern Tools for Drug Discovery ??? Lipophilicity/ Membrane Affinity ADME- Optimised Compounds HSA Binding logMA Log K d,HSA PK-Map TM

Modern Tools for Drug Discovery PK-Map TM...via Physiology-based ADME Models PHYSIOLOGICAL PROPERTIES organ volume and composition, blood flow rates, pH, effective accessible surface area, gastric emptying and intestinal transit time, feeding status,... Physico-chemical-/ in vitro properties membrane affinity HSA binding solubility molecular weight... Pharmacokinetic-/ADME- in vivo properties fraction dose absorbed organ/plasma PC free serum concentration volume of distribution...

Modern Tools for Drug Discovery Validation of the Absorption Model Human F abs calculated only from MA and Mw compared to published in vivo data Willmann et al., J. Med. Chem. 2004,47, pp Excellent agreement All outliers known as substrates for active transporters. Compound set (126 marketed drugs)

Modern Tools for Drug Discovery Validation of the Distribution Model organ/plasma partition coefficients K org/water

Modern Tools for Drug Discovery Combination of TRANSIL  and PK-MAP ™ * as the most reliable tool for ADME Prediction PK-MAP ™ * Lipophilicity/ Membrane Affinity ADME- Optimised Compounds HSA Binding logMA Additional Input Solubility, MW Log K d,HSA Conclusions

Modern Tools for Drug Discovery TRANSIL  and TRANSIL  -HSA Benefits and Summary Determination of lipophilicity and serum binding in real High Throughput Processing time is less than one minute per drug in the 384 well format First 384 well assay for both parameters Small amount of compound needed Easy handling: Compound addition, separation, quantification Correlation with established approaches and to ADME parameters High throughput assays for high quality data